Liver

**Vegan Meal Study Reveals Surprising Liver Benefits** – Findings show significant reduction in harmful ammonia levels after just one plant-based meal!

by

Richmond, Virginia – A recent study conducted by researchers from Virginia Commonwealth University’s School of Medicine and Richmond VA Medical Center has shown promising results for liver patients suffering from cirrhosis. The study, published in the Clinical and Translational Gastroenterology journal, found that switching to a vegan or vegetarian diet for just one meal can significantly reduce harmful ammonia levels in adults with liver damage. In the study, a group of 30 carnivorous adults with …

Read more

Liver Grown Inside Human in Groundbreaking Medical Milestone!

by

PITTSBURGH, PA – Breakthrough medical research in Pennsylvania has recently achieved a significant milestone in the field of regenerative medicine. LyGenesis, a biotech company based in Pittsburgh, has successfully administered an innovative cell therapy treatment to a human patient, marking a crucial advancement in the quest to grow organs inside the body. In a Phase 2a clinical trial conducted by LyGenesis, a patient suffering from end-stage liver disease (ESLD) received a groundbreaking injection of donated …

Read more

Revolutionary Double Lung and Liver Transplant Saves Pulmonologist’s Life After Late-Stage Cancer Diagnosis

by

Santa Monica, California – Dr. Gary Gibbon, a pulmonologist, was taken aback when he received a diagnosis of lung disease, especially considering his clean bill of health prior to the illness. Despite never having any significant medical history or regular medication use, Gibbon found himself facing advanced stage lung cancer at the age of 69. In the United States, lung cancer is the leading cause of cancer-related deaths, claiming about 1 in every 5 lives …

Read more

Breakthrough: FDA Approves First Drug for Liver Disease Scarring – Rezdiffra Offers Hope for Millions

by

Washington, D.C. – The U.S. Food and Drug Administration (FDA) recently granted approval for a groundbreaking treatment for individuals suffering from a severe liver condition. The medication, known as Rezdiffra (resmetirom), is designed to address nonalcoholic steatohepatitis (NASH), a form of liver inflammation commonly linked to fatty liver disease. NASH, also referred to as metabolic dysfunction-associated steatohepatitis (MASH), is characterized by liver inflammation caused by an accumulation of fatty cells. If left untreated, NASH can …

Read more

**Weight-loss drug market explodes with new liver disease treatment shaking up industry** **Liver Disease Treatment Trial Results Sends Zealand Pharma Shares Soaring – Could This Be the Next Big Weight Loss Drug?** **Liver Disease Treatment Breakthrough Rattles Pharma Industry: Is This the Future of Weight Loss Drugs?**

by

Hillerod, Denmark – The pharmaceutical industry has seen a surge in competition following the success of Novo Nordisk A/S’s weight-loss drugs, Ozempic and Wegovy. This success has prompted around 40 companies to develop products that aim to compete in this lucrative market. The production facilities in Hillerod, Denmark, are busy with vials moving along conveyors, symbolizing the bustling activity in the industry. Zealand Pharma, a Denmark-based company, experienced a significant increase in its stock value …

Read more

Ozempic Study Reveals Shocking Impact on Liver Health for Diabetics

by

STOCKHOLM, Sweden – A recent nationwide study conducted by the Karolinska Institutet in Sweden has found a potential link between the use of GLP1 agonists such as Ozempic and a reduced risk of cirrhosis and liver cancer in individuals with type 2 diabetes and chronic liver disease. The results of the study, which were published in the journal Gut, suggest a promising new treatment option for preventing severe liver diseases. GLP1 agonists are known for …

Read more